Nantahala Capital Management, LLC Catalyst Biosciences, Inc. Transaction History

Nantahala Capital Management, LLC

$1.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.2 - $0.35 $18,526 - $32,420	-92,630 Reduced 57.74%	67,800 $23,000
Q1 2023 May 15, 2023	SELL	$0.19 - $0.64 $52,748 - $177,680	-277,625 Reduced 63.38%	160,430 $33,000
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.57 $1.04 Million - $1.21 Million	-2,116,680 Reduced 82.85%	438,055 $232,000
Q3 2022 Nov 10, 2022	SELL	$0.49 - $1.95 $98,572 - $392,277	-201,168 Reduced 7.3%	2,554,735 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$0.36 - $1.78 $120,641 - $596,502	335,114 Added 13.84%	2,755,903 $4.91 Million
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $173,844 - $340,871	-340,871 Reduced 12.34%	2,420,789 $1.6 Million
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $299,797 - $1.37 Million	329,448 Added 13.55%	2,761,660 $2.52 Million
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $374,779 - $513,586	-99,148 Reduced 3.92%	2,432,212 $10 Million
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $122,893 - $159,761	-29,974 Reduced 1.17%	2,531,360 $11 Million
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $3.43 Million - $4.98 Million	696,000 Added 37.31%	2,561,334 $12.9 Million
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $198,311 - $317,734	43,585 Added 2.39%	1,865,334 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $1.41 Million - $3 Million	375,000 Added 25.92%	1,821,749 $10.7 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $8.51 $1.31 Million - $3.19 Million	375,000 Added 34.99%	1,446,749 $6.32 Million
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $40,255 - $70,446	8,906 Added 0.84%	1,071,749 $7.3 Million
Q3 2019 Nov 14, 2019	BUY	$4.91 - $9.31 $98,200 - $186,200	20,000 Added 1.92%	1,062,843 $5.22 Million
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $598,968 - $896,760	84,600 Added 8.83%	1,042,843 $7.69 Million
Q1 2019 May 15, 2019	BUY	$7.67 - $9.96 $790,010 - $1.03 Million	103,000 Added 12.04%	958,243 $7.77 Million
Q4 2018 Feb 14, 2019	BUY	$6.59 - $11.28 $5.64 Million - $9.65 Million	855,243 New	855,243 $6.75 Million

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account